Literature DB >> 3678490

The geometries of interacting arginine-carboxyls in proteins.

J Singh1, J M Thornton, M Snarey, S F Campbell.   

Abstract

The geometries are reported for interacting arginine-carboxyl pairs obtained from 37 high resolution protein structures solved to a resolution of 2.0 A or better. The closest interatomic distance between the guanidinium and carboxyl is less than 4.2 A for 74 arginine and carboxyl groups, with the majority of these lying within hydrogen-bonding distance (2.6-3.0 A). Interacting pairs have been transformed into a common orientation, and arginine-carboxyl, and carboxyl-arginine geometries have been calculated. This has been defined in terms of the spherical polar angles T theta, T phi, and the angle P, between the guanidinium and carboxyl planes. Results show a clear preference for the guanidinium and carboxyl groups to be approximately coplanar, and for the carboxyl oxygens to hydrogen bond with the guanidinium nitrogens. Single nitrogen-single oxygen is the most common type of interaction, however twin nitrogen-twin oxygen interactions also occur frequently. The majority of these occur between the carboxyl oxygens and the NH1 and NE atoms of the arginine, and are only rarely observed for NH1 and NH2. The information presented may be of use in the modelling of arginine-carboxyl interactions within proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678490     DOI: 10.1016/0014-5793(87)80441-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Salt bridges: geometrically specific, designable interactions.

Authors:  Jason E Donald; Daniel W Kulp; William F DeGrado
Journal:  Proteins       Date:  2011-01-05

2.  IsoStar: a library of information about nonbonded interactions.

Authors:  I J Bruno; J C Cole; J P Lommerse; R S Rowland; R Taylor; M L Verdonk
Journal:  J Comput Aided Mol Des       Date:  1997-11       Impact factor: 3.686

3.  Geometries of functional group interactions in enzyme-ligand complexes: guides for receptor modelling.

Authors:  M Tintelnot; P Andrews
Journal:  J Comput Aided Mol Des       Date:  1989-03       Impact factor: 3.686

4.  A computer modeling postulated mechanism for angiotensin II receptor activation.

Authors:  M P Joseph; B Maigret; J C Bonnafous; J Marie; H A Scheraga
Journal:  J Protein Chem       Date:  1995-07

5.  Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.

Authors:  J Féthière; Y Tsuda; R Coulombe; Y Konishi; M Cygler
Journal:  Protein Sci       Date:  1996-06       Impact factor: 6.725

6.  Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site.

Authors:  J H Matthews; R Krishnan; M J Costanzo; B E Maryanoff; A Tulinsky
Journal:  Biophys J       Date:  1996-11       Impact factor: 4.033

7.  Contribution of unusual arginine-arginine short-range interactions to stabilization and recognition in proteins.

Authors:  A Magalhaes; B Maigret; J Hoflack; J N Gomes; H A Scheraga
Journal:  J Protein Chem       Date:  1994-02

8.  Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.

Authors:  Mallesh Beesu; Giuseppe Caruso; Alex C D Salyer; Karishma K Khetani; Diptesh Sil; Mihiri Weerasinghe; Hiromi Tanji; Umeharu Ohto; Toshiyuki Shimizu; Sunil A David
Journal:  J Med Chem       Date:  2015-09-22       Impact factor: 7.446

9.  Combined High-Pressure and Multiquantum NMR and Molecular Simulation Propose a Role for N-Terminal Salt Bridges in Amyloid-Beta.

Authors:  Sahithya Phani Babu Vemulapalli; Stefan Becker; Christian Griesinger; Nasrollah Rezaei-Ghaleh
Journal:  J Phys Chem Lett       Date:  2021-10-07       Impact factor: 6.475

10.  Polydiacetylenyl β-cyclodextrin based smart vesicles for colorimetric assay of arginine and lysine.

Authors:  Eunae Cho; Hwanhee Kim; Youngjin Choi; Seung R Paik; Seunho Jung
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.